A national clinical research investigational site network known as Platinum Research Network (PRN) recently included a new trial site organization in California called Mills Clinical Research, extending the network from one coast to the other.
In a recent press release, PRN showcased its successful tactics in supporting the COVID-19 pandemic vaccine research effort introducing “new technologies and methods to scale up delivery of predictable enrolment and high-quality data” in a bid to support the acceleration of COVID-19 vaccines.
PRN positions its geographic diversity with a mix of trial site locations across urban, suburban, and rural locations.
To date, Platinum Research Network research centers have enrolled more than 15,000 clinical trial participants into COVID-19 vaccine studies including adults, older adults, children, and pregnant patients. PRN Members include MedPharmics, Meridian Clinical Research, Sterling Research Group, Sundance Clinical Research, Tekton Research, Ventavia Research Group – and now Mills Clinical Research.
Mills Clinical Research
The new addition to PRN is based in Los Angeles, CA, and is led by Dr. Anthony Mills...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).